Newsfile Corp
27 Sept 2026, 02:22 UTC · 3h ago
Verdict
Headline takes no side. We score CAPR −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
Capricor Therapeutics is facing a securities class action alleging it failed to disclose that the FDA had not agreed to changes in the statistical analysis plan for Deramiocel prior to its BLA resubmission.
Priced inlawsuit has already been filed
So whatRegulatory rejection of the BLA would eliminate the primary near-term catalyst for the company's valuation.
More negative than 95% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The lawsuit claims Capricor's modifications to the clinical data analysis for Deramiocel created a significant risk that the FDA would find the therapy lacked substantial evidence of effectiveness.
Priced inlawsuit has already been filed
So whatFailure to prove effectiveness for Duchenne muscular dystrophy would likely lead to a total write-down of the asset's projected revenue.
More negative than 85% of claims this week
The deadline for investors who purchased CAPR securities between December 17, 2025, and July 26, 2026, to move for lead plaintiff status is September 28, 2026.
Newpress release dated September 26
So whatThe immediate 48-hour window increases the probability of high-profile institutional plaintiffs joining the litigation.
More negative than 63% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities class action lawsuit alleging misleading statements regarding clinical data and FDA approval risks.
More negative than 73% of ticker scores this week
The company is mentioned as being subject to a securities class action lawsuit.
More negative than 73% of ticker scores this week
The company is mentioned as being subject to a securities class action lawsuit.
More negative than 73% of ticker scores this week
The company is mentioned as being subject to a securities class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
3h ago
—
CAPR hasn't traded since this ran. Last close $8.36 (Sep 25); the reaction starts at the next open.
CAPR chart →
